FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicholas Lowe

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Nicholas Lowe; Stephen Horwitz; Emil Tanghetti; Zoe Diana Draelos; Alan Menter
Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.
Helen Torok; Susan Taylor; Leslie Baumann; Terry Jones; Joshua Wieder; Nicholas Lowe; Michael Jarret; Phoebe Rich; David M Pariser; Eduardo Tschen; Dale Martin; Alan Menter; Jonathan Weiss
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.
Nicholas Lowe; Steven R Feldman; Daniel Sherer; Jonathan Weiss; Joel Shavin; Yin Lui Lin; Valerie Foley; Pascale Soto
Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicholas Lowe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Nicholas Lowe; Stephen Horwitz; Emil Tanghetti; Zoe Diana Draelos; Alan Menter
Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.
Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 2006;8(3):121-7.
2005: Helen Torok; Susan Taylor; Leslie Baumann; Terry Jones; Joshua Wieder; Nicholas Lowe; Michael Jarret; Phoebe Rich; David M Pariser; Eduardo Tschen; Dale Martin; Alan Menter; Jonathan Weiss
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.
Journal of drugs in dermatology : JDD 2005;4(5):592-7.
2005: Nicholas Lowe; Steven R Feldman; Daniel Sherer; Jonathan Weiss; Joel Shavin; Yin Lui Lin; Valerie Foley; Pascale Soto
Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
The Journal of dermatological treatment 2005;16(3):158-64.
2005: Sewon Kang; Wilma F Bergfeld; Alice B Gottlieb; Janet Hickman; John Humeniuk; Steven Kempers; Mark Lebwohl; Nicholas Lowe; Amy McMichael; James Milbauer; Tania Phillips; Jerold Powers; David Rodriguez; Ronald Savin; Joel Shavin; Daniel Sherer; Nancy Silvis; Richard Weinstein; Jonathan Weiss; Craig Hammerberg; Gary J Fisher; Marge Nighland; Rachel Grossman; Judit Nyirady
Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial.
American journal of clinical dermatology 2005;6(4):245-53.
2004: M Pauporte; Howard I Maibach; Nicholas Lowe; M Pugliese; D J Friedman; H Mendelsohn; I Cargill; R Ramirez
Fluocinolone acetonide topical oil for scalp psoriasis.
The Journal of dermatological treatment 2004;15(6):360-4.
2004: Nicholas Lowe; Michael Gifford; Emil Tanghetti; Yves Poulin; Mitchel Goldman; Yardy Tse; Paul Yamauchi; Helene Rosenzweig; Sewon Kang
Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 2004;6(2):79-85.
2003: Raza Aly; George Fisher; Irving Katz; Norman Levine; Donald P Lookingbill; Nicholas Lowe; Alan Menter; Manuel Morman; David M Pariser; Harry L Roth; Ronald Savin; Joel Shavin; Daniel Stewart; J Richard Taylor; Stephen Tucker; Mitchell Wortzman
Ciclopirox gel in the treatment of patients with interdigital tinea pedis.
International journal of dermatology 2003;42 Suppl 1():29-35.
2003: Raza Aly; H Irving Katz; Steven Kempers; Donald P Lookingbill; Nicholas Lowe; Alan Menter; Manuel Morman; Ronald Savin; Mitchell Wortzman
Ciclopirox gel for seborrheic dermatitis of the scalp.
International journal of dermatology 2003;42 Suppl 1():19-22.
2003: Susan C Taylor; Helen Torok; Terry Jones; Nicholas Lowe; Phoebe Rich; Eduardo Tschen; Alan Menter; Leslie Baumann; Joshua J Wieder; Michael M Jarratt; David M Pariser; Dale Martin; Jonathan Weiss; Joel Shavin; Nini Ramirez
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Cutis; cutaneous medicine for the practitioner 2003;72(1):67-72.
2001: James J Leyden; Nicholas Lowe; L Kakita; Zoe Diana Draelos
Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.
Cutis; cutaneous medicine for the practitioner 2001;67(6 Suppl):10-6.
1999: H H Roenigk; J P Callen; CA Guzzo; H Irving Katz; Nicholas Lowe; K Madison; TP Nigra; VC Fiedler; R B Armstrong
Effects of acitretin on the liver.
Journal of the American Academy of Dermatology 1999;41(4):584-8.
1999: Janet L Roberts; VC Fiedler; J Imperato-McGinley; David A Whiting; Elise Olsen; Jerome L Shupack; Dow Stough; R DeVillez; R Rietschel; Ronald Savin; Wilma F Bergfeld; James M Swinehart; T Funicella; Maria Hordinsky; Nicholas Lowe; Irving Katz; Anne W Lucky; LA Drake; Vera H Price; D Weiss; Susan E Whitmore; L Millikan; S Muller; C Gencheff
Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
Journal of the American Academy of Dermatology 1999;41(4):555-63.
1999: LA Drake; Maria Hordinsky; VC Fiedler; James M Swinehart; WALTER UNGER; P C Cotterill; Diane M Thiboutot; Nicholas Lowe; C Jacobson; David A Whiting; S Stieglitz; S J Kraus; E I Griffin; D Weiss; P Carrington; C Gencheff; G W Cole; David M Pariser; Edwin S Epstein; Wesley Tanaka; aimee dallob; K Vandormael; LA Geissler; Joanne Waldstreicher
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
Journal of the American Academy of Dermatology 1999;41(4):550-4.
1997: Jerome L Shupack; E Abel; E Bauer; M Brown; LA Drake; R Freinkel; CA Guzzo; J Koo; N Levine; Nicholas Lowe; C McDonald; D Margolis; M Stiller; B Wintroub; C Bainbridge; S Evans; S Hilss; W Mietlowski; C Winslow; J E Birnbaum
Cyclosporine as maintenance therapy in patients with severe psoriasis.
Journal of the American Academy of Dermatology 1997;36(3 Pt 1):423-32.
1997: Ronald Savin; R L De Villez; B Elewski; S Hong; T Jones; Nicholas Lowe; Anne W Lucky; B Reyes; D Stewart; I Willis
One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
Journal of the American Academy of Dermatology 1997;36(2 Pt 1):S15-9.
1992: Brian Berman; Charles Ellis; James J Leyden; Nicholas Lowe; Ronald Savin; Jerome L Shupack; M Stiller; Eduardo Tschen; N Zaias; J E Birnbaum
Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials.
Journal of the American Academy of Dermatology 1992;26(6):956-60.